Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma
| Record | Firm | Date |
|---|---|---|
| Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma (NCT03985189) | Kyowa Kirin Co., Ltd. | 2019-04-29 |
Track Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.